Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Let's Banish the Bias in AI Models
Bioinformatics Clinical care Digital and computational pathology Laboratory management Training and education Opinion and Personal Narratives Voices in the Community Professional Development Digital Pathology

Let's Banish the Bias in AI Models

Why AI equity matters in pathology – and why I'm fighting for a fairer AI future

By Bamidele Farinre 04/13/2026 Opinion 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Share

Clinical Report: Let's Banish the Bias in AI Models

Overview

This report highlights the urgent need to address biases in AI models used in healthcare, particularly those that under-represent women and ethnic minorities. The proposed project by the UK's All-Party Parliamentary Group aims to explore these biases and promote equitable AI practices in STEM fields.

Background

The integration of artificial intelligence (AI) in healthcare has the potential to enhance diagnostics and decision-making, especially in under-resourced areas. However, the risk of perpetuating existing biases in AI models poses significant challenges, including misdiagnosis and eroded trust among patients. Addressing these biases is crucial for ensuring equitable healthcare delivery and fostering public confidence in AI technologies.

Data Highlights

No numerical data available in the source material.

Key Findings

  • AI models often learn from datasets that under-represent women and ethnic minorities.
  • Algorithms trained on lighter skin tones may miss critical changes in melanin-rich samples.
  • Facial-analysis tools exhibit higher failure rates for women of color.
  • Gendered harms in AI can exacerbate existing inequalities in STEM fields.
  • The APPG's project aims to gather diverse voices to inform policy recommendations for equitable AI.

Clinical Implications

Healthcare professionals must be aware of the biases inherent in AI technologies and advocate for diverse datasets and inclusive design practices. Engaging in initiatives like the APPG's project can help shape a future where AI serves as an ally in healthcare rather than a source of inequality.

Conclusion

Addressing bias in AI is essential for advancing equitable healthcare practices. Collaborative efforts are needed to ensure that AI technologies enhance rather than hinder progress in diagnostics and patient care.

References

  1. van Genderen et al., Intensive Care Medicine, 2024 -- The Limitations of Federated Learning in Addressing Ingrained Biases in Clinical Medicine
  2. Enhancing Governance of Healthcare AI with a Detailed Maturity Model Derived from Systematic Review Findings, npj Digital Medicine, 2026
  3. Open-Source Large Language Models and AI Health Equity: A Health Service Triangle Model Perspective, JMIR, 2026
  4. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
  5. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening, Nature Medicine, 2024
  6. aace endocrine ai — Regulating the algorithms of health care 
  7. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
  8. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening | Nature Medicine
  9. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Bamidele Farinre

Bamidele Farinre is a Chartered Biomedical Scientist, Agile Project Manager, and Author of The Mentor’s Journey, From Learning to Leading.

More Articles by Bamidele Farinre

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Patient Is More Than a Price Tag
Bioinformatics
A Patient Is More Than a Price Tag

November 17, 2016

1 min read

In patients with intellectual and metabolic differences, genome-wide sequencing can provide diagnoses and even potential routes to treatment

This Time, It’s Personal
Bioinformatics
This Time, It’s Personal

October 25, 2022

5 min read

Overcoming lung cancer treatment resistance will require predictive biomarkers that take into account significant patient variability

Sepsis Patient Risk Scores
Bioinformatics
A Calculated Risk

February 15, 2023

2 min read

How a personalized sepsis score aims to better stratify patients with acute infection

The Google Genome
Bioinformatics
The Google Genome

November 17, 2014

1 min read

The tech giant’s newest “moonshot” aims to create a complete genomic picture of the healthy human being

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.